Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ou SI, Kim ES. Response to: Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? J Thorac Oncol 2023;18:e30-e31.
PMID: 36842818


Privacy Policy